CellX Biosolutions, an ETH Zurich-born startup, is excited to announce that it has successfully raised 1,900,000 in funding to further advance its mission of rethinking chemical pollutant treatment. This new capital injection marks a pivotal milestone for the company, which is dedicated to offering a revolutionary alternative to traditional, costly methods such as incineration. By harnessing nature’s own master recyclers—bacteria—CellX Biosolutions is setting a new standard in environmental remediation. The funding will be strategically used to scale its patented microtechnology, designed for deployment directly in remote and challenging environments. This innovative approach allows the capture of unique bacterial consortia with enhanced capabilities to degrade specific micropollutants, including microplastics, PFAS, pesticides, and pharmaceuticals. Once isolated, these highly efficient biological solutions are scaled up into powerful cultures of degraders envisioned for direct application in chemical storage reservoirs and wastewater treatment plants across various industries.
With this fresh round of funding, CellX Biosolutions is positioned to accelerate its research and development efforts, expand its operational footprint, and intensify partnerships with key stakeholders in the environmental and industrial sectors. The company's commitment to steering away from unsustainable incineration practices towards a greener, more cost-effective method of pollutant degradation highlights a transformative shift in chemical waste management. As the challenges of chemical pollution continue to escalate globally, CellX Biosolutions’ approach not only offers a scalable, eco-friendly solution but also sets the stage for broader implementation of biologically driven environmental remediation techniques. This funding round underscores investor confidence in the company’s vision and its potential to reshape the future of chemical waste treatment.
